Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2010
02/04/2010WO2010013864A1 Use of microrna in treating or preventing solid cancers
02/04/2010WO2010013849A1 Gpr119 agonist
02/04/2010WO2010013815A1 Composition for inhibiting expression of target gene
02/04/2010WO2010013805A1 Aminopropylidene derivative
02/04/2010WO2010013798A1 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof
02/04/2010WO2010013794A1 Spiroaminodihydrothiazine derivatives
02/04/2010WO2010013769A1 Crystal of thiazolidinedione compound, and process for production thereof
02/04/2010WO2010013768A1 Crystal of thiazolidinedione compound, and process for production thereof
02/04/2010WO2010013640A1 Potentiator of therapeutic efficacy on infectious disease
02/04/2010WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
02/04/2010WO2010013551A1 Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside
02/04/2010WO2010013474A1 Ceramide production promoter
02/04/2010WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor
02/04/2010WO2010013302A1 Spiroaminodihydrothiazine derivative
02/04/2010WO2010013242A1 Substituted pyridoxine-lactam carboxylate salts
02/04/2010WO2010013240A1 Compositions and methods for treating inflammatory disorders
02/04/2010WO2010013231A2 Modulation of coagulation factors and effectors of same for control of transplant organ size
02/04/2010WO2010013224A2 Curcumin nanoparticles and methods of producing the same
02/04/2010WO2010013222A1 Pyrrole carboxylic acid derivatives as antibacterial agents
02/04/2010WO2010013204A1 Composition for regenerating senescent cutaneous and sub-cutaneous tissue, products and uses thereof
02/04/2010WO2010013187A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor
02/04/2010WO2010013168A1 3',6-substituted indirubins and their biological applications
02/04/2010WO2010013161A1 Fluorinated heteroaryls
02/04/2010WO2010013158A1 Phenanthrenone compounds, compositions and methods
02/04/2010WO2010013129A1 Coccidiocide combination for veterinary use
02/04/2010WO2010013127A1 Benzimidazole-derived compounds used as markers in the case of neurodegenerative diseases
02/04/2010WO2010013110A2 Composition comprising an association of active principles for use in the topical treatment of baldness
02/04/2010WO2010013086A1 Phosphorylated dendrimers as antiinflammatory drugs
02/04/2010WO2010013078A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
02/04/2010WO2010013050A1 Process for the preparation of o-desmethylvenlafaxine
02/04/2010WO2010013048A1 Polymorphic form of rasagiline mesylate
02/04/2010WO2010013044A1 Nalmefene and derivatives thereof for the treatment of skin disorders
02/04/2010WO2010013037A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists
02/04/2010WO2010013011A1 P53 tumor suppressor protein activating
02/04/2010WO2010012965A2 Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic “apoptosis” pathway in the treatment of cancer
02/04/2010WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
02/04/2010WO2010012904A2 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method
02/04/2010WO2010012840A1 Use of nucleoside analogs as anti-koi herpes virus molecules
02/04/2010WO2010012817A2 5ht7 receptor ligands and compositions comprising the same
02/04/2010WO2010012812A1 Benzazepines and benzazocines as sigma-receptor ligandes
02/04/2010WO2010012806A2 Substituted indole sulfonamide compounds, their preparation and use as medicaments
02/04/2010WO2010012789A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds
02/04/2010WO2010012777A1 THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT
02/04/2010WO2010012761A1 Dimeric derivatives of artemisinin and application in anti-cancer therapy
02/04/2010WO2010012758A1 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
02/04/2010WO2010012747A1 New compounds
02/04/2010WO2010012745A2 Benzimidazoles
02/04/2010WO2010012740A1 5-alkynyl-pyrimidines
02/04/2010WO2010012733A1 Use of a cdk inhibitor for the treatment of glioma
02/04/2010WO2010012714A1 Nitrogenated derivatives of pancratistatin
02/04/2010WO2010012667A1 Micro-rna mediated modulation of colony stimulating factors
02/04/2010WO2010012650A1 Compounds for the treatment of metabolic diseases
02/04/2010WO2010012620A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
02/04/2010WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors
02/04/2010WO2010012611A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
02/04/2010WO2010012567A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology
02/04/2010WO2010012507A1 Biologically active silicic acid
02/04/2010WO2010012506A1 Cannabinoids for use in treating or preventing cognitive impairment and dementia
02/04/2010WO2010012490A1 Quetiapine composition
02/04/2010WO2010012482A1 Ropinirole composition
02/04/2010WO2010012471A1 Salts of tramadol and ibuprofen and their crystal form in the treatment of pain
02/04/2010WO2010012466A1 Antitumor properties of no modified protease inhibitors
02/04/2010WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor
02/04/2010WO2010012398A1 Substituted pyridines, and use thereof as gsk3 inhibitors
02/04/2010WO2010012397A1 N-(indol-3-ylalkyl)(hetero)arylamide derivatives as modulators of the ep2 receptor
02/04/2010WO2010012396A1 5,6 substituted benzamide derivatives as modulators of the ep<sb>2 </sb>receptor
02/04/2010WO2010012381A1 Streptospirole derivatives
02/04/2010WO2010012345A1 Imidazothiadiazoles derivatives
02/04/2010WO2010012319A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
02/04/2010WO2010012248A1 Telmisartan tablets
02/04/2010WO2010012153A1 Phlorizin derivatives and their preparation and application
02/04/2010WO2010012138A1 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimino)pyrrolidin-1-yl] quinoline carboxylic acid derivatives and methods for preparation
02/04/2010WO2010012131A1 The usage of medicinal composition containing oil of zedoary turmeric in manufacture of medicaments
02/04/2010WO2010012127A1 Use of a traditional chinese medicinal composition for preparing medicine for promoting bone marrow-derived mesenchymal stem cell survival in vivo and cardiac muscle differentiation
02/04/2010WO2010012121A1 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
02/04/2010WO2010012107A1 Selective glycosidase inhibitors and uses thereof
02/04/2010WO2010012106A1 Selective glycosidase inhibitors and uses thereof
02/04/2010WO2010012043A1 Methods and compositions
02/04/2010WO2010012039A1 Process for recovering proteins from crustacean exoskeletons
02/04/2010WO2010012037A1 6-substituted isoflavonoid compounds and uses thereof
02/04/2010WO2009153569A3 Cb1 receptor modulators
02/04/2010WO2009152392A3 Muscarinic agonists for neurological disorders and methods of making the same
02/04/2010WO2009151496A9 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells
02/04/2010WO2009150257A3 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
02/04/2010WO2009150179A3 Plant extract and pufa combinations
02/04/2010WO2009149258A3 Crystalline form of 6-[(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
02/04/2010WO2009146807A8 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
02/04/2010WO2009137801A3 Inhibitory rnas that regulate hematopoietic cells
02/04/2010WO2009137611A9 Treatment of pulmonary fungal infection with voriconazole via inhalation
02/04/2010WO2009135135A3 Fibromodulin formulation for reducing corneal scarring
02/04/2010WO2009134404A3 Steroidal compounds as melanogenesis modifiers and uses thereof
02/04/2010WO2009131952A8 Compounds, compositions and methods comprising thiazole derivatives
02/04/2010WO2009131384A3 Pharmaceutical composition for preventing and treating malaria, containing compounds that inhibit plasmepsin ii activity, and method of treating malaria using the same
02/04/2010WO2009129525A3 Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
02/04/2010WO2009129511A4 Fluocinolone formulations in a biodegradable polymer carrier
02/04/2010WO2009129208A3 Compositions and methods of inducing endoplasmic reticulum stress reponse
02/04/2010WO2009117242A3 Aqueous pharmaceutical compositions containing borate-polyol complexes
02/04/2010WO2009114540A9 Vitamin d compounds and methods for reducing ocular hypertension (oht)
02/04/2010WO2009108760A8 Dendritic macroporous hydrogels prepared by crystal templating
02/04/2010WO2009103788A9 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres
1 ... 2391 2392 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 ... 7860